ZappRx, a digital health company that streamlines the specialty medication prescribing process, has partnered with Dunn Meadow, a national specialty pharmacy, headquartered in New Jersey. Traditionally focused on oncology, the partnership with ZappRx allows Dunn Meadow to expand its patient population to include pulmonology and other disease states that require a high touch service model.
Dunn Meadow is a fully accredited specialty pharmacy with URAC, ACHC, and VIPPS. While the pharmacy is physically located in Fort Lee, New Jersey, Dunn Meadow serves patients across the U.S. and employs pharmacists with SPCB (Specialty Pharmacy Certification Board) certifications.
By integrating ZappRx’s specialty prescribing and prior authorization platform, Dunn Meadow will significantly reduce the time it takes to deliver medications to their patients. The organization will be listed on ZappRx’s platform for providers to choose as a specialty pharmacy option, for the medications and treatment areas they serve. For ZappRx, Dunn Meadow’s flow of information will give healthcare providers visibility into when prescriptions are received, filled, and shipped.
ZappRx provides physicians with a comprehensive digital solution for specialty prescribing and prior authorizations, versus the current paper-based process reliant on fax machines. Providers using the ZappRx platform are able to increase their prescription approval rate to 96 percent in a matter of days, even when dealing with the most complex cases.
(Source: ZappRx)
